Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins

Clinical and Experimental Dermatology

Volumn 34, Issue 5, 2009, Pages 613-617

  Kurzawski, M ^a   Modrzejewski, A ^a   Pawlik, A ^a   Drozdzik M ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VARICOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, GENETIC; VARICOSE VEINS; YOUNG ADULT;

EID: 66449104347     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03166.x     Document Type: Article

References (25)

1. Naoum JJ, Hunter GC, Woodside KJ, Chen C. Current advances in the pathogenesis of varicose veins. J Surg Res 2007 141 : 311 16.
2. Sudol-Szopinska I, Blachowiak K, Kozinski P. Influence of environmental risk factors on the development of chronic vein insufficiency. Med Pr 2006 57 : 365 73.
3. Hanemaaijer R, Koolwijk P, le Clercq L et al. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993 296 : 803 9.
4. Cornu-Thenard A, Boivin P, Baud JM et al. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994 20 : 318 26.
5. Pistorius MA. Chronic venous insufficiency: the genetic influence. Angiology 2003 54 (Suppl. 1 S5 12.
6. Mellor RH, Brice G, Stanton AW et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007 115 : 1912 20.
7. Venturi M, Bonavina L, Annoni F et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res 1996 60 : 245 8.
8. Travers JP, Brookes CE, Evans J et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996 11 : 230 7.
9. Sellers A, Murphy G. Collagenolytic enzymes and their naturally occurring inhibitors. Int Rev Connect Tissue Res 1998 9 : 151 90.
10. Gillespie DL, Patel A, Fileta B et al. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res 2002 106 : 233 8.
11. Woodside KJ, Hu M, Burke A et al. Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg 2003 38 : 162 9.
12. Kowalewski R, Sobolewski K, Wolanska M, Gacko M. Matrix metalloproteinases in the vein wall. Int Angiol 2004 23 : 164 9.
13. Sansilvestri-Morel P, Rupin A, Jullien ND et al. Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res 2005 42 : 388 98.
14. Sansilvestri-Morel P, Fioretti F, Rupin A et al. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? Clin Sci 2007 112 : 229 39.
15. Rutter JL, Mitchell TI, Buttice G et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998 58 : 5321 5.
16. Lievre A, Milet J, Carayol J et al. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer 2006 6 : 270.
17. Ye S, Eriksson P, Hamsten A et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996 271 : 13055 60.
18. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006 69 : 636 45.
19. Ye S, Patodi N, Walker-Bone K et al. Variation in the matrix metalloproteinase-3-7-12 and -13 genes is associated with functional status in rheumatoid arthritis. Int J Immunogenet 2007 34 : 81 5.
20. Gustincich S, Manfioletti G, Del Sal G et al. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991 11 : 298 302.
21. Jurajda M, Muzik J, Izakovicova Holla L, Vacha J. A newly identified single nucleotide polymorphism in the promoter of the matrix metalloproteinase-1 gene. Mol Cell Probes 2002 16 : 63 6.
22. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A polymorphism. Atherosclerosis 2000 151 : 587 9.
23. Sansilvestri-Morel P, Rupin A, Jaisson S et al. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002 106 : 479 83.
24. Ishikawa Y, Asuwa N, Ishii T et al. Collagen alteration in vascular remodeling by hemodynamic factors. Virchows Arch 2000 437 : 138 48.
25. Parra JR, Cambria RA, Hower CD et al. Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg. J Vasc Surg 1998 28 : 669 75.